Sorry, you need to enable JavaScript to visit this website.

Report

Report

State economic scorecard 2026


The scorecard assesses and ranks the performance of each Australian state across ten economic indicators: annual growth in per capita gross state product, annual wage growth, jobs growth, retail turnover, tax burden, debt burden, productivity growth, business investment, rental affordability and energy affordability. Western Australia is the best performing state and New South Wales the...
Report

Blue report: regional breakdown – April 2026


This report provides an analysis of how the November 2025 Medicare changes have impacted general practitioner accessibility across metropolitan and regional Australia, providing region-based insights. It compares the capital city and non-capital city areas of each state to determine whether accessibility gaps remain and exactly where they are. The trends are mixed but encouraging.
Report

For the people: future-proofing Australia’s democracy


Australia is one of the world’s leading democracies, but cannot take it for granted. This report shows that democracy is backsliding globally, and the world order in which Australia has flourished is being seriously tested. The report identifies five priorities for Australia to build a better and more resilient democracy.
Report

Workforce pressures facing the food and grocery manufacturing sector


This report examines workforce pressures facing Australia’s food and grocery manufacturing sector, setting a focus for long-term solutions. The report provides a macro assessment of workforce challenges affecting the sector. Key occupations in focus for this report include food and drink factory workers; packers; forklift drivers; purchasing and supply logistics clerks; and manufacturing production managers.
Report

Still out of pocket: why 43 per cent of Australians are missing out on cheaper medicines


The Australian Government’s Cheaper Medicines policy commenced in January 2026. Despite the reforms starting to take effect, there is a growing risk that many Australians who rely on non-PBS subsidised medicines will continue to be impacted by out-of-pocket costs. This report considers this challenge and outlines a way forward to expand the cheaper medicines program.